Cargando…

CD8(+) T Cells Specific to Apoptosis-Associated Antigens Predict the Response to Tumor Necrosis Factor Inhibitor Therapy in Rheumatoid Arthritis

CD8(+) T cells specific to caspase-cleaved antigens derived from apoptotic T cells (apoptotic epitopes) represent a principal player in chronic immune activation, which is known to amplify immunopathology in various inflammatory diseases. The purpose of the present study was to investigate the relat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Citro, Alessandra, Scrivo, Rossana, Martini, Helene, Martire, Carmela, De Marzio, Paolo, Vestri, Anna Rita, Sidney, John, Sette, Alessandro, Barnaba, Vincenzo, Valesini, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465029/ https://www.ncbi.nlm.nih.gov/pubmed/26061065 http://dx.doi.org/10.1371/journal.pone.0128607

Ejemplares similares

(1)H-NMR-Based Metabolomic Study for Identifying Serum Profiles Associated with the Response to Etanercept in Patients with Rheumatoid Arthritis
por: Priori, Roberta, et al.
Publicado: (2015)

Increased CD8(+) T cell responses to apoptotic T cell-associated antigens in multiple sclerosis
por: Lolli, Francesco, et al.
Publicado: (2013)

Application of a Stochastic Modeling to Assess the Evolution of Tuberculous and Non-Tuberculous Mycobacterial Infection in Patients Treated with Tumor Necrosis Factor Inhibitors
por: Agliari, Elena, et al.
Publicado: (2013)

The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus
por: Scrivo, Rossana, et al.
Publicado: (2017)

Rheumatic Diseases and Obesity: Adipocytokines as Potential Comorbidity Biomarkers for Cardiovascular Diseases
por: Scrivo, Rossana, et al.
Publicado: (2013)

Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases
por: Sauzullo, Ilaria, et al.
Publicado: (2018)

Dietary Habits Bursting into the Complex Pathogenesis of Autoimmune Diseases: The Emerging Role of Salt from Experimental and Clinical Studies
por: Scrivo, Rossana, et al.
Publicado: (2019)

Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis
por: Di Franco, Manuela, et al.
Publicado: (2018)

Periodontitis and Rheumatoid Arthritis: The Same Inflammatory Mediators?
por: Ceccarelli, Fulvia, et al.
Publicado: (2019)

Post-translational modifications in rheumatoid arthritis and atherosclerosis: Focus on citrullination and carbamylation
por: Spinelli, Francesca Romana, et al.
Publicado: (2016)

Potential role of platelets for atherosclerotic events in rheumatoid arthritis
por: Vona, Rosa, et al.
Publicado: (2018)

Autophagy and Rheumatoid Arthritis: Current Knowledges and Future Perspectives
por: Vomero, Marta, et al.
Publicado: (2018)

Influence of tumor necrosis factor α in rheumatoid arthritis
por: Kulp, Werner, et al.
Publicado: (2005)

Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement
por: Bombardieri, Michele, et al.
Publicado: (2004)

Inducible Treg cell populations as cell based-therapy for rheumatoid arthritis
por: Martire, Delphine, et al.
Publicado: (2012)

Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
por: Spinelli, Francesca Romana, et al.
Publicado: (2017)

Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems
por: Valesini, Guido, et al.
Publicado: (2009)

Erratum to: Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
por: Spinelli, Francesca Romana, et al.
Publicado: (2017)

Neurocognitive Dysfunction in Systemic Lupus Erythematosus: Association with Antiphospholipid Antibodies, Disease Activity and Chronic Damage
por: Conti, Fabrizio, et al.
Publicado: (2012)

Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis for Function and Pain is Affected by Rheumatoid Factor
por: Aberumand, Babak, et al.
Publicado: (2014)

Polyfunctional Type-1, -2, and -17 CD8(+) T Cell Responses to Apoptotic Self-Antigens Correlate with the Chronic Evolution of Hepatitis C Virus Infection
por: Franceschini, Debora, et al.
Publicado: (2012)

Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies
por: Ali Khan, Wahid
Publicado: (2018)

Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor
por: Solehan, Hana Maizuliana bt, et al.
Publicado: (2011)

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
por: Leandro, Maria J
Publicado: (2009)

Are interferon-gamma release assays reliable to detect tuberculosis infection in patients with rheumatoid arthritis treated with Janus kinase inhibitors?
por: Scrivo, Rossana, et al.
Publicado: (2022)

Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
por: Shin, Sungsik, et al.
Publicado: (2016)

Serum Levels of Asymmetric Dimethylarginine and Apelin as Potential Markers of Vascular Endothelial Dysfunction in Early Rheumatoid Arthritis
por: Di Franco, Manuela, et al.
Publicado: (2012)

The rheumatoid arthritis specific Sa antigen is citrullinated vimentin
por: Vossenaar, ER, et al.
Publicado: (2004)

Yoga, rheumatoid arthritis & human leukocyte antigen-G
por: Mittal, Balraj
Publicado: (2022)

Increased Prevalence of Human Polyomavirus JC Viruria in Chronic Inflammatory Rheumatic Diseases Patients in Treatment with Anti-TNF α: A 18 Month Follow-Up Study
por: Rodio, Donatella Maria, et al.
Publicado: (2016)

Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis
por: Martínez-Santana, Virginia, et al.
Publicado: (2013)

Life-Threatening Gastrointestinal Mucosal Necrosis during Methotrexate Treatment for Rheumatoid Arthritis
por: Tsukada, Tomoya, et al.
Publicado: (2013)

Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis
por: Perpétuo, Inês P., et al.
Publicado: (2017)

Tumor necrosis factor α-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis
por: Inoue, Asuka, et al.
Publicado: (2009)

TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis
por: Barbati, Cristiana, et al.
Publicado: (2018)

Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
por: Yang, Nicole, et al.
Publicado: (2019)

Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor
por: Ernestam, Sofia, et al.
Publicado: (2006)

Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
por: Tanaka, Toshio, et al.
Publicado: (2014)

Tumor Necrosis Factor Inhibition and Head and Neck Cancer Recurrence and Death in Rheumatoid Arthritis
por: Phillips, Christopher, et al.
Publicado: (2015)

Efficacy predictors of a second tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis
por: Reams, Jennifer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0cq1s2tdbhmifluphlklmefg1e